Blog
Foundation Awardees Present Research at ISPOR 2022
The PhRMA Foundation recognized recipients of its 2021 and 2022 fellowships and grants on May 17 at ISPOR 2022 in ...
Read More
Read More
Researcher Spotlight: Protecting Pregnant People Through Novel Health Outcomes Research
Foundation award winner Dr. Mollie Wood studies the use during pregnancy of medications that treat chronic conditions ...
Read More
Read More
Celebrating the Frontiers of Science on National DNA Day
Today we celebrate National DNA Day, commemorating the groundbreaking 1953 publications in the journal Nature by James Watson, Francis Crick, Maurice ...
Read More
Read More
Incorporating Patient Preferences into the Field of Value Assessment
Although I was trained as a pharmacist and studied health economics, early work in my career with multiple sclerosis patients ...
Read More
Read More
An Interview with PhRMA Foundation Chairman Andy Plump
2021 was a year of leadership transition for the PhRMA Foundation, with Amy Miller joining as President and Andy Plump, ...
Read More
Read More
Building on the PhRMA Foundation’s Little-Known History
The PhRMA Foundation has quietly been doing its work for 57 years. When I joined as its President late last ...
Read More
Read More
Towards Better Data Dashboards for Cost-Effectiveness Analyses
Assessing the value of a specific drug or medical intervention is a complicated, multilayered process. Conventional cost-effectiveness ratios (i.e., in ...
Read More
Read More
What Low-Value Care Means for Health Equity
The coronavirus pandemic has laid bare the significant health disparities present within the American health care system. Not only has ...
Read More
Read More
The Patient Perspective Approach Should Guide Value Assessments of COVID-19 Vaccines
As the United States continues its mass rollout of the COVID-19 vaccine, key questions remain concerning how policymakers should value ...
Read More
Read More
